Company profilePharmaceutical#332 of 1,318 in Pakistan4 DRAP alerts

ALKEMY PHARMACEUTICAL LABORATORIES (PRIVATE) LTD.

Pharmaceutical company · 53 brands · 57 molecules

53 registered products 23 pharmaceutical brands 57 distinct molecules 4 DRAP alerts

Company overview

53
registered products
23
pharmaceutical brands
57
distinct molecules
0
therapeutic classes
4
DRAP alerts

ALKEMY PHARMACEUTICAL LABORATORIES (PRIVATE) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 53 product registrations across 57 distinct molecules. DRAP has issued 4 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Regulatory record

4 alerts in the DRAP feed we track.

Recall Alert: Drug Product; Kemodryl Cough Syrup (Batch # K-1068) by Alkemy Pharmaceutical
2023-10-26
Recall Alert: Drug Product; Kemygyl 200mg/5mL oral Suspension (Batch # M-319) by M/s. Alke
2023-09-14
Recall Alert: Drug Product; Kempol 120ml/5mL Pediatric Syrup by M/s Alkemy Pharmaceutical
2022-12-01
Drug Product Recalls: Cozol Suspension (Batch # E206) By M/S. Alkemy Pharmaceutical Labora
2022-02-08

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for ALKEMY

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.